JP2004526429A5 - - Google Patents

Download PDF

Info

Publication number
JP2004526429A5
JP2004526429A5 JP2002556746A JP2002556746A JP2004526429A5 JP 2004526429 A5 JP2004526429 A5 JP 2004526429A5 JP 2002556746 A JP2002556746 A JP 2002556746A JP 2002556746 A JP2002556746 A JP 2002556746A JP 2004526429 A5 JP2004526429 A5 JP 2004526429A5
Authority
JP
Japan
Prior art keywords
filed
provisional application
application
entirety
contents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002556746A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004526429A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/047349 external-priority patent/WO2002055700A2/en
Publication of JP2004526429A publication Critical patent/JP2004526429A/ja
Publication of JP2004526429A5 publication Critical patent/JP2004526429A5/ja
Withdrawn legal-status Critical Current

Links

JP2002556746A 2000-12-07 2001-12-07 ヒト前立腺から単離したヒト遺伝子および遺伝子発現産物 Withdrawn JP2004526429A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25464800P 2000-12-07 2000-12-07
US27568801P 2001-03-13 2001-03-13
PCT/US2001/047349 WO2002055700A2 (en) 2000-12-07 2001-12-07 Human genes and gene expression products isolated from human prostate

Publications (2)

Publication Number Publication Date
JP2004526429A JP2004526429A (ja) 2004-09-02
JP2004526429A5 true JP2004526429A5 (cg-RX-API-DMAC10.html) 2005-05-26

Family

ID=26944174

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002556746A Withdrawn JP2004526429A (ja) 2000-12-07 2001-12-07 ヒト前立腺から単離したヒト遺伝子および遺伝子発現産物

Country Status (5)

Country Link
EP (1) EP1379651A2 (cg-RX-API-DMAC10.html)
JP (1) JP2004526429A (cg-RX-API-DMAC10.html)
AU (1) AU2002243300A1 (cg-RX-API-DMAC10.html)
CA (1) CA2430794A1 (cg-RX-API-DMAC10.html)
WO (1) WO2002055700A2 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030215803A1 (en) * 2000-12-07 2003-11-20 Garcia Pablo Dominguez Human genes and gene expression products isolated from human prostate
WO2002060953A2 (en) 2000-12-15 2002-08-08 Agensys, Inc. Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
US8647826B2 (en) 2001-03-14 2014-02-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
WO2005080562A1 (ja) * 2004-02-23 2005-09-01 Hiroshi Yamamoto 前立腺癌の判定方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218529B1 (en) * 1995-07-31 2001-04-17 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
US6476207B1 (en) * 1998-06-11 2002-11-05 Chiron Corporation Genes and gene expression products that are differentially regulated in prostate cancer

Similar Documents

Publication Publication Date Title
CY2019029I1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
JP2003531157A5 (cg-RX-API-DMAC10.html)
JP2002334588A5 (cg-RX-API-DMAC10.html)
JP2004525194A5 (cg-RX-API-DMAC10.html)
JP2005529946A5 (cg-RX-API-DMAC10.html)
JP2004500211A5 (cg-RX-API-DMAC10.html)
CY2014038I2 (el) Αντι-il-6 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
NO20041216L (no) Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt
JP2004210767A5 (cg-RX-API-DMAC10.html)
DK1697378T3 (da) Indoler, 1H-indazoler, 1,2-benzisoxazoler og 1,2-benzisothiazoler og fremstilling og anvendelser deraf
NO20041200L (no) Fremgangsmate for fremstilling av citalopram.
JP2003510400A5 (cg-RX-API-DMAC10.html)
EP1531795A4 (en) FORMULATIONS FOR LIMITING THE RETENTION OF LUNG INFECTIONS
JP2005536763A5 (cg-RX-API-DMAC10.html)
JP2005527457A5 (cg-RX-API-DMAC10.html)
JP2005005118A5 (cg-RX-API-DMAC10.html)
JP2002277470A5 (cg-RX-API-DMAC10.html)
JP2002275230A5 (cg-RX-API-DMAC10.html)
DK1450626T3 (da) Ny ikke-antibiotisk strategi mod OGIP-infektioner på basis af et aktiveret kornprodukt
JP2007523200A5 (cg-RX-API-DMAC10.html)
NO20040912L (no) Beskyttede 3,5-dihydroksy-2,2-dimetyl-valeroamider for syntese av epotiloner og derivater derav, og fremgangsmate for fremstilling og andvendelse derav.
JP2003140040A5 (cg-RX-API-DMAC10.html)
JP2000021571A5 (cg-RX-API-DMAC10.html)
JP2006501280A5 (cg-RX-API-DMAC10.html)
JP2004517145A5 (cg-RX-API-DMAC10.html)